Articles > Popular publications > PR Newswire press releases > January-March 2008 > Monday, March 17

Article: Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma.

Article from:
PR Newswire
Article date:
March 17, 2008
Copyright

SYMBICORT Was Well Tolerated in 26-Week Study

WILMINGTON, Del., March 17 /PRNewswire-FirstCall/ -- A new study analyzed long-term use of the maintenance combination asthma therapy, SYMBICORT(R) (budesonide/formoterol fumarate dihydrate), in treating persistent asthma in children 6 to 11 years old. The study examined the safety of SYMBICORT in children for 26 weeks and also included efficacy measures. For children previously treated with inhaled corticosteroid, either alone or in combination, the study showed that long-term treatment with SYMBICORT resulted in significantly greater improvements in lung function and reduced healthcare resource utilization, compared ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Study Analyzed SYMBICORT(R) in Children with Persistent ...
PR Newswire;  May 20, 2008 ;     700+ words ... ... reporting any adverse events, regardless ... similar for SYMBICORT (70.3 ... related adverse events for all treatment ... groups were SYMBICORT (3.1 ... discontinuation of SYMBICORT.(2) The ... related adverse events reported ...

Article: Long-Term Safety Profile of SYMBICORT[R] Analyzed in ...
Immunotherapy Weekly;  September 3, 2008 ;     700+ words ... ... exacerbations and adverse events.1 The study showed that SYMBICORT, a combination ... experienced any adverse events were similar for both dosing arms of SYMBICORT (88.9%, four ... 88.7%).1 Adverse events were mainly mild ...

Article: Pivotal Data Showed Symbicort[R] Improved Lung Function In ...
Biotech Week;  November 19, 2008 ;     700+ words ... ... 1 oBoth doses of SYMBICORT were well-tolerated ... pneumonia-related adverse events were similar for all ... treatment groups, except SYMBICORT 80/4.5 mcg, compared ... common drug-related adverse events were oral candidiasis ... and tolerability of SYMBICORT was assessed in a 12 ...

Article: Pivotal Data Showed SYMBICORT(R) Improved Lung Function in ...
PR Newswire;  October 29, 2008 ;     700+ words ... ... Both doses of SYMBICORT were well-tolerated ... pneumonia-related adverse events were similar for all ... treatment groups, except SYMBICORT 80/4.5 mcg, compared ... common drug-related adverse events were oral candidiasis ... and tolerability of SYMBICORT was assessed in a 12 ...

Article: FDA Approves SYMBICORT(R) for Chronic Obstructive ...
PR Newswire;  February 27, 2009 ;     700+ words ... ... pneumonia was no different for SYMBICORT compared to placebo.(2 ... infections) in patients receiving SYMBICORT 160/4.5 mcg than in those ... most common drug-related adverse events reported were nasopharyngitis ... Through these pivotal studies, SYMBICORT demonstrated rapid and sustained ...

Article: Approved Asthma Therapy SYMBICORT Improves Lung Function ...
PR Newswire;  November 13, 2006 ;     700+ words ... ... 001) in the SYMBICORT group compared ... placebo groups. The adverse events (AEs) profile for SYMBICORT was similar to ... Treatment-related adverse events (reported by ... jitteriness. Overall, SYMBICORT was generally well ...

Article: AstraZeneca Submits an sNDA for SYMBICORT(R) for the ...
PR Newswire;  June 4, 2008 ;     700+ words ... ... studies demonstrated that SYMBICORT 80/9 mcg twice daily had ... first study also found that SYMBICORT 80/9 mcg twice daily had ... formoterol.(5) The most common adverse events reported were headache, pyrexia ... another important milestone for SYMBICORT, and we look forward to discussions ...

Article: AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD ...
PR Newswire;  April 30, 2008 ;     700+ words ... ... Los Angeles (UCLA). "If SYMBICORT receives approval from the ... trials, SHINE and SUN, with SYMBICORT pressurized metered dose inhaler ... 3) The most common adverse events found in these trials were ... very severe COPD.(3) -- SYMBICORT 160/4.5 micrograms (mcg ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives